{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:35:04Z","timestamp":1785497704089,"version":"3.56.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ymthe.2025.10.004","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:04:25Z","timestamp":1759791865000},"page":"734-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer viroimmunotherapy platforms based on varicella-zoster virus and cytomegalovirus"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6451-4236","authenticated-orcid":false,"given":"Haifei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Whye","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.10.004_bib1","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.abk3436","article-title":"Oncolytic virotherapy as immunotherapy","volume":"374","author":"Melcher","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.10.004_bib2","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1038\/s41467-024-49286-x","article-title":"Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response","volume":"15","author":"Webb","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.10.004_bib3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41467-024-55455-9","article-title":"Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma","volume":"16","author":"Grimes","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.10.004_bib4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-024-00760-x","article-title":"An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy","volume":"5","author":"Chen","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.004_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ccell.2018.03.011","article-title":"Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines","volume":"33","author":"Russell","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.10.004_bib6","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116738119","article-title":"Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors","volume":"119","author":"Cuburu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.10.004_bib7","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2003-06-2125","article-title":"Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells","volume":"103","author":"Verneris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.004_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cytogfr.2020.06.005","article-title":"The two-faces of NK cells in oncolytic virotherapy","volume":"56","author":"Marotel","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ymthe.2025.10.004_bib9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s43018-022-00448-0","article-title":"Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity","volume":"3","author":"Tian","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.004_bib10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1158\/2326-6066.CIR-24-0852","article-title":"Adaptive NK Cells Exhibit Tumor-Specific Immune Memory and Cytotoxicity in Ovarian Cancer","volume":"13","author":"Sun","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.10.004_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/leu.2015.260","article-title":"CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT","volume":"30","author":"Cichocki","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2025.10.004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.omto.2023.100729","article-title":"Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment","volume":"31","author":"Khushalani","year":"2023","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2025.10.004_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123514","article-title":"HSV-1 Oncolytic Viruses from Bench to Bedside: An Overview of Current Clinical Trials","volume":"12","author":"Koch","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2025.10.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2020.03.004","article-title":"Tumor Control by Cytomegalovirus: A Door Open for Oncolytic Virotherapy?","volume":"17","author":"Herbein","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2025.10.004_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008307","article-title":"Oncolytic varicella-zoster virus engineered with ORF8 deletion and armed with drug-controllable interleukin-12","volume":"12","author":"Jiang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.004_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ymthe.2023.11.003","article-title":"Oncolytic alpha-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses","volume":"32","author":"Jiang","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.004_bib17","article-title":"Oncolytic cytomegaloviruses expressing EGFR-retargeted fusogenic glycoprotein complex and drug-controllable interleukin 12","volume":"6","author":"Jiang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymthe.2025.10.004_bib18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/mt.2016.121","article-title":"Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity","volume":"24","author":"Erkes","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.004_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2042-4280-3-5","article-title":"Herpes simplex virus and varicella zoster virus, the house guests who never leave","volume":"3","author":"Kinchington","year":"2012","journal-title":"Herpesviridae"},{"key":"10.1016\/j.ymthe.2025.10.004_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/mmbr.00116-22","article-title":"Creating the \u201cDew Drop on a Rose Petal\u201d: the Molecular Pathogenesis of Varicella-Zoster Virus Skin Lesions","volume":"87","author":"Arvin","year":"2023","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ymthe.2025.10.004_bib21","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/JVI.02592-07","article-title":"Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia","volume":"82","author":"Reichelt","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2017.00105","article-title":"gammadelta T Cell-Mediated Immunity to Cytomegalovirus Infection","volume":"8","author":"Khairallah","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib23","first-page":"341","article-title":"VZV T cell-mediated immunity","volume":"342","author":"Weinberg","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/315347","article-title":"Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression","volume":"181","author":"Asanuma","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.10.004_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006346","article-title":"Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration","volume":"13","author":"Gonzalez-Motos","year":"2017","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2025.10.004_bib26","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1038\/s41467-024-49657-4","article-title":"Viral modulation of type II interferon increases T cell adhesion and virus spread","volume":"15","author":"Jacobsen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.10.004_bib27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/eji.201570044","article-title":"5(th) International Workshop on CMV and Immunosenescence - A shadow of cytomegalovirus infection on immunological memory","volume":"45","author":"Arens","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe6968","article-title":"Human cytomegalovirus expands a CD8(+) T cell population with loss of BCL11B expression and gain of NK cell identity","volume":"6","author":"Sottile","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib29","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20041851","article-title":"Shared reactivity of Vdelta2(neg) gammadelta T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells","volume":"201","author":"Halary","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.10.004_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1681\/ASN.2008101072","article-title":"Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation","volume":"21","author":"Couzi","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib31","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/0008-5472.CAN-08-3037","article-title":"Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model","volume":"69","author":"Devaud","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.004_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/1097-0142(195305)6:3<591::AID-CNCR2820060317>3.0.CO;2-M","article-title":"Remissions in leukemia of childhood following acute infectious disease: staphylococcus and streptococcus, varicella, and feline panleukopenia","volume":"6","author":"Bierman","year":"1953","journal-title":"Cancer"},{"key":"10.1016\/j.ymthe.2025.10.004_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/bmt.2014.290","article-title":"Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients","volume":"50","author":"Kamber","year":"2015","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.ymthe.2025.10.004_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221122729","article-title":"Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature","volume":"14","author":"Khoury","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib35","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/cam4.682","article-title":"History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC)","volume":"5","author":"Amirian","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.ymthe.2025.10.004_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073741","article-title":"Human Cytomegalovirus Oncoprotection across Diverse Populations, Tumor Histologies, and Age Groups: The Relevance for Prospective Vaccinal Therapy","volume":"25","author":"Jankovic","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.10.004_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jocn.2019.03.051","article-title":"Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report","volume":"64","author":"Lamano","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.ymthe.2025.10.004_bib38","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","article-title":"Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients","volume":"118","author":"Elmaagacli","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.004_bib39","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/bmt.2013.49","article-title":"CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML","volume":"48","author":"Ito","year":"2013","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.ymthe.2025.10.004_bib40","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/bloodadvances.2022009376","article-title":"CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia","volume":"7","author":"Akahoshi","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.10.004_bib41","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/s41591-025-03647-1","article-title":"CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade","volume":"31","author":"Milotay","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.10.004_bib42","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.20020797","article-title":"A signal peptide derived from hsp60 binds HLA-E and interferes with CD94\/NKG2A recognition","volume":"196","author":"Michaelsson","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.10.004_bib43","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.micinf.2010.07.011","article-title":"The other Janus face of Qa-1 and HLA-E: diverse peptide repertoires in times of stress","volume":"12","author":"van Hall","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ymthe.2025.10.004_bib44","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood-2005-09-3682","article-title":"Expansion of CD94\/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts","volume":"107","author":"Guma","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.004_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164809","article-title":"Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma","volume":"133","author":"Huuhtanen","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.10.004_bib46","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1038\/s41598-019-39345-5","article-title":"Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment","volume":"9","author":"Iwahori","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.10.004_bib47","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T cells","volume":"186","author":"Hamann","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.10.004_bib48","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/eji.201847771","article-title":"Blimp-1 induces and Hobit maintains the cytotoxic mediator granzyme B in CD8 T cells","volume":"48","author":"Kragten","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib49","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI5409","article-title":"Implication of gammadelta T cells in the human immune response to cytomegalovirus","volume":"103","author":"Dechanet","year":"1999","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.ymthe.2025.10.004_bib50","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood-2008-01-136713","article-title":"Long-term expansion of effector\/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection","volume":"112","author":"Pitard","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.004_bib51","doi-asserted-by":"crossref","DOI":"10.1097\/BS9.0000000000000213","article-title":"gammadelta T cells in hematological malignancies: mechanisms and therapeutic strategies","volume":"7","author":"Chen","year":"2025","journal-title":"Blood Sci."},{"key":"10.1016\/j.ymthe.2025.10.004_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1080","article-title":"gammadelta T cells in cancer: a small population of lymphocytes with big implications","volume":"8","author":"Raverdeau","year":"2019","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib53","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1988.00380070065016","article-title":"Varicella-zoster infection in adult cancer patients. A population study","volume":"148","author":"Rusthoven","year":"1988","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymthe.2025.10.004_bib54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.37201\/req\/s03.16.2022","article-title":"Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies","volume":"35","author":"Garcia-Bustos","year":"2022","journal-title":"Rev. Esp Quimioter"},{"key":"10.1016\/j.ymthe.2025.10.004_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/v15020439","article-title":"Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients","volume":"15","author":"Tayyar","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.10.004_bib56","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1158\/1078-0432.CCR-20-0369","article-title":"Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients","volume":"26","author":"Stragliotto","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.004_bib57","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.clinthera.2018.07.006","article-title":"Antiviral Therapies for Herpesviruses: Current Agents and New Directions","volume":"40","author":"Poole","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ymthe.2025.10.004_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040872","article-title":"Friend or Foe? Exploring the Role of Cytomegalovirus (HCMV) Infection in Head and Neck Tumors","volume":"12","author":"Trivic","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2025.10.004_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16111970","article-title":"Cellular Transformation by Human Cytomegalovirus","volume":"16","author":"Herbein","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2025.10.004_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.730765","article-title":"Immune Landscape of CMV Infection in Cancer Patients: From \u201cCanonical\u201d Diseases Toward Virus-Elicited Oncomodulation","volume":"12","author":"El Baba","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00430-015-0411-4","article-title":"Human cytomegalovirus: taking the strain","volume":"204","author":"Wilkinson","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050166","article-title":"Recombinant human cytomegalovirus (HCMV) RL13 binds human immunoglobulin G Fc","volume":"7","author":"Cortese","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.004_bib63","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/jmv.24484","article-title":"Functional analysis of human cytomegalovirus UL\/b' region using SCID-hu mouse model","volume":"88","author":"Dulal","year":"2016","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib64","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1099\/vir.0.021931-0","article-title":"Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112","volume":"91","author":"Prod'homme","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib65","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.4049\/jimmunol.175.11.7457","article-title":"Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis","volume":"175","author":"Wills","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib66","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1074\/jbc.RA119.009199","article-title":"Structure of human cytomegalovirus UL144, an HVEM orthologue, bound to the B and T cell lymphocyte attenuator","volume":"294","author":"Bitra","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.10.004_bib67","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416114122","article-title":"Viral and host network analysis of the human cytomegalovirus transcriptome in latency","volume":"122","author":"Collins-McMillen","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.10.004_bib68","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/21645515.2017.1391433","article-title":"Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy","volume":"14","author":"Xia","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2025.10.004_bib69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3181\/00379727-160-40382","article-title":"Clinical and laboratory studies of live cytomegalovirus vaccine Ad-169","volume":"160","author":"Neff","year":"1979","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ymthe.2025.10.004_bib70","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-016-0653-5","article-title":"Cytomegalovirus Vaccines: Current Status and Future Prospects","volume":"76","author":"Anderholm","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2025.10.004_bib71","first-page":"1176","article-title":"Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients","volume":"58","author":"Plotkin","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2025.10.004_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/219439","article-title":"Recombinant varicella-zoster virus vaccines as platforms for expression of foreign antigens","volume":"2013","author":"Gray","year":"2013","journal-title":"Adv. Virol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/infdis\/149.2.137","article-title":"Clinical reinfection with varicella-zoster virus","volume":"149","author":"Gershon","year":"1984","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.10.004_bib74","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/cid\/cir033","article-title":"Varicella reinfection in a seropositive physician following occupational exposure to localized zoster","volume":"52","author":"Johnson","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.10.004_bib75","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1128\/JVI.01067-12","article-title":"The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation","volume":"86","author":"Peters","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/v15102043","article-title":"Exploring the Potential of Cytomegalovirus-Based Vectors: A Review","volume":"15","author":"Zeng","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.10.004_bib77","first-page":"155","article-title":"Varicella zoster virus immune evasion strategies","volume":"342","author":"Abendroth","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib78","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.10.004_bib79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1185350","article-title":"Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus","volume":"328","author":"Hansen","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.10.004_bib80","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s42003-022-04254-3","article-title":"Repeated dosing improves oncolytic rhabdovirus therapy in mice via interactions with intravascular monocytes","volume":"5","author":"Naumenko","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib81","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.ymthe.2018.07.002","article-title":"Oncolytic Virotherapy: Single Cycle Cures or Repeat Treatments? (Repeat Dosing Is Crucial!)","volume":"26","author":"Melcher","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.004_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/v14112327","article-title":"Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus","volume":"14","author":"Ding","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.10.004_bib83","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ymthe.2018.01.019","article-title":"Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy","volume":"26","author":"Ricca","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.004_bib84","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/JVI.02127-08","article-title":"Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamsters","volume":"83","author":"Dhar","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","article-title":"Clinical trial links oncolytic immunoactivation to survival in glioblastoma","volume":"623","author":"Ling","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.10.004_bib86","article-title":"Human Cytomegalovirus Cell Tropism and Host Cell Receptors","volume":"7","author":"Gerna","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2025.10.004_bib87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41698-024-00709-4","article-title":"Clinical implications of cytomegalovirus in glioblastoma progression and therapy","volume":"8","author":"Mercado","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib88","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-017-0179-7","article-title":"Anterograde monosynaptic transneuronal tracers derived from herpes simplex virus 1 strain H129","volume":"12","author":"Zeng","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2025.10.004_bib89","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1080\/21505594.2021.1980990","article-title":"Herpes simplex virus interference with immunity: Focus on dendritic cells","volume":"12","author":"Ma","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.ymthe.2025.10.004_bib90","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1128\/JVI.75.13.6183-6192.2001","article-title":"Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host","volume":"75","author":"Abendroth","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib91","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00693-21","article-title":"Murine Cytomegalovirus MCK-2 Facilitates In Vivo Infection Transfer from Dendritic Cells to Salivary Gland Acinar Cells","volume":"95","author":"Ma","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib92","article-title":"The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles","volume":"24","author":"Tang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.10.004_bib93","article-title":"Emerging delivery strategy for oncolytic virotherapy","volume":"32","author":"Zhu","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib94","first-page":"1137","article-title":"Varicella zoster virus infection of malignant glioma cell cultures: a new candidate for oncolytic virotherapy?","volume":"32","author":"Leske","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ymthe.2025.10.004_bib95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.virol.2016.06.017","article-title":"Analysis of single nucleotide polymorphism among Varicella-Zoster Virus and identification of vaccine-specific sites","volume":"496","author":"Jeon","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2025.10.004_bib96","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/JVI.72.2.965-974.1998","article-title":"Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse","volume":"72","author":"Moffat","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.12","article-title":"Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma","volume":"3","author":"Kumar","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2025.10.004_bib98","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.omto.2020.01.007","article-title":"Uncovering the Anticancer Potential of Murine Cytomegalovirus against Human Colon Cancer Cells","volume":"16","author":"Massara","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2025.10.004_bib99","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00533-19","article-title":"Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor","volume":"93","author":"Wilski","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib100","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm7515","article-title":"CD8(+) T cell targeting of tumor antigens presented by HLA-E","volume":"10","author":"Iyer","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.10.004_bib101","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/CJI.0b013e3182585d50","article-title":"A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer","volume":"35","author":"Klyushnenkova","year":"2012","journal-title":"J. Immunother."},{"key":"10.1016\/j.ymthe.2025.10.004_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006072","article-title":"Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors","volume":"12","author":"Dekhtiarenko","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2025.10.004_bib103","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2326-6066.CIR-14-0044","article-title":"Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma","volume":"3","author":"Qiu","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.10.004_bib104","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.3390\/ijms20153626","article-title":"Battle between Host Immune Cellular Responses and HCMV Immune Evasion","volume":"20","author":"Manandhar","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.10.004_bib105","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s43018-025-00998-z","article-title":"A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial","volume":"6","author":"Thompson","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.004_bib106","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1172\/JCI138649","article-title":"Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.10.004_bib107","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1080\/21645515.2017.1331795","article-title":"Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity","volume":"13","author":"Erkes","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2025.10.004_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc14e04s24","article-title":"Human cytomegalovirus: bacterial artificial chromosome (BAC) cloning and genetic manipulation","author":"Paredes","year":"2012","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.ymthe.2025.10.004_bib109","article-title":"Increasing the Efficiency of CRISPR\/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells","volume":"6","author":"Lin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.10.004_bib110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jviromet.2014.05.027","article-title":"Laboratory preparation of Varicella-Zoster Virus: concentration of virus-containing supernatant, use of a debris fraction and magnetofection for consistent cell-free VZV infections","volume":"206","author":"Sloutskin","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ymthe.2025.10.004_bib111","article-title":"Merck & Co., Inc. Stabilizers Containing Recombinant Human Serum Albumin for Live Virus Vaccines","author":"Burke","year":"2022","journal-title":"Google Patents US6210683B1"},{"key":"10.1016\/j.ymthe.2025.10.004_bib112","article-title":"Merck & Co., Inc. Process for Attenuated Varicella Zoster Virus Vaccine Production","author":"Provost","year":"1997","journal-title":"Google Patents EP0573107B1"},{"key":"10.1016\/j.ymthe.2025.10.004_bib113","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3390\/v13122481","article-title":"Production- and Purification-Relevant Properties of Human and Murine Cytomegalovirus","volume":"13","author":"Ravlic","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.10.004_bib114","doi-asserted-by":"crossref","DOI":"10.3390\/v13071271","article-title":"Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes","volume":"13","author":"Malogolovkin","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.10.004_bib115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004462","article-title":"The use of oncolytic virotherapy in the neoadjuvant setting","volume":"10","author":"Thomas","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.004_bib116","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/vaccines12090958","article-title":"An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer","volume":"12","author":"Forcic","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2025.10.004_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103743","article-title":"Immunity to SARS-CoV-2 up to 15 months after infection","volume":"25","author":"Marcotte","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2025.10.004_bib118","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1038\/s41467-024-51498-0","article-title":"Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy","volume":"15","author":"Taha","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:33:01Z","timestamp":1770222781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625008251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1525001625008251"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.004","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer viroimmunotherapy platforms based on varicella-zoster virus and cytomegalovirus","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}